These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 7982438)

  • 1. The roles of alpha-glucosidase inhibitors in diabetes.
    Donckier J; Williams G
    Eur J Clin Invest; 1994 Aug; 24(8):522-4. PubMed ID: 7982438
    [No Abstract]   [Full Text] [Related]  

  • 2. New horizons in diabetes therapy--alpha glucosidase inhibitors.
    Jawad F
    J Pak Med Assoc; 1994 Mar; 44(3):59-60. PubMed ID: 8040998
    [No Abstract]   [Full Text] [Related]  

  • 3. [Alpha-glucosidase inhibitors: a new therapeutic approach in diabetes and functional hypoglycemia].
    Brogard JM; Willemin B; Blicklé JF; Lamalle AM; Stahl A
    Rev Med Interne; 1989; 10(4):365-74. PubMed ID: 2678346
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Combined therapy with insulin and alpha-glucosidase inhibitor].
    Watanabe K; Kawamori R
    Nihon Rinsho; 1997 Nov; 55 Suppl():261-6. PubMed ID: 9434478
    [No Abstract]   [Full Text] [Related]  

  • 5. [Combination therapy with insulin and alpha-glucosidase inhibitor].
    Watanabe K; Kawamori R
    Nihon Rinsho; 2002 Sep; 60 Suppl 9():447-51. PubMed ID: 12387032
    [No Abstract]   [Full Text] [Related]  

  • 6. Alpha-glucosidase inhibitors for patients with type 2 diabetes: response to van de Laar et al.
    Hanefeld M; Josse RG; Chiasson JL
    Diabetes Care; 2005 Jul; 28(7):1840; author reply 1841. PubMed ID: 15983359
    [No Abstract]   [Full Text] [Related]  

  • 7. α-Glucosidase and α-amylase inhibitors from seed oil: A review of liposoluble substance to treat diabetes.
    Teng H; Chen L
    Crit Rev Food Sci Nutr; 2017 Nov; 57(16):3438-3448. PubMed ID: 26854322
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Targeting α -(1,4)-Glucosidase in Diabetes Mellitus Type 2: The Role of New Synthetic Coumarins as Potent Inhibitors.
    Figueroa-Benavides C; Matos MJ; Peñaloza-Amion M; Veas R; Valenzuela-Barra G; Zapata G; Delogu G; Uriarte E; Santana L; Olea-Azar C; Delporte C
    Curr Top Med Chem; 2018; 18(27):2327-2337. PubMed ID: 30499400
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Guideliness for drug treatment of type 2 diabetes mellitus].
    Ann Endocrinol (Paris); 2000 May; 61(2):168-73. PubMed ID: 10891670
    [No Abstract]   [Full Text] [Related]  

  • 10. Recent Advances in Synthetic α-Glucosidase Inhibitors.
    Liu Z; Ma S
    ChemMedChem; 2017 Jun; 12(11):819-829. PubMed ID: 28498640
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pyridine sulfonamide as a small key organic molecule for the potential treatment of type-II diabetes mellitus and Alzheimer's disease: In vitro studies against yeast α-glucosidase, acetylcholinesterase and butyrylcholinesterase.
    Riaz S; Khan IU; Bajda M; Ashraf M; Qurat-Ul-Ain ; Shaukat A; Rehman TU; Mutahir S; Hussain S; Mustafa G; Yar M
    Bioorg Chem; 2015 Dec; 63():64-71. PubMed ID: 26451651
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Potential pharmacokinetics interference between alpha-glucosidase inhibitors and other oral antidiabetic agents.
    Scheen AJ; Lefèbvre PJ
    Diabetes Care; 2002 Jan; 25(1):247-8. PubMed ID: 11772929
    [No Abstract]   [Full Text] [Related]  

  • 13. [Sulfonylurea and alpha-glucosidase inhibitor].
    Iijima T
    Nihon Rinsho; 2002 Sep; 60 Suppl 9():459-63. PubMed ID: 12387034
    [No Abstract]   [Full Text] [Related]  

  • 14. Food protein-derived bioactive peptides in management of type 2 diabetes.
    Patil P; Mandal S; Tomar SK; Anand S
    Eur J Nutr; 2015 Sep; 54(6):863-80. PubMed ID: 26154777
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rapid improvement of serum 1,5-anhydroglucitol concentrations after administration of alpha-glucosidase inhibitor.
    Yoshioka K; Azukari K; Yoshida T; Kondo M
    Diabetes Care; 1997 Mar; 20(3):462. PubMed ID: 9051408
    [No Abstract]   [Full Text] [Related]  

  • 16. [Alpha-glucosidase inhibitor].
    Osonoi T
    Nihon Rinsho; 2015 Mar; 73(3):390-4. PubMed ID: 25812363
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Galangin inhibits α-glucosidase activity and formation of non-enzymatic glycation products.
    Zeng L; Ding H; Hu X; Zhang G; Gong D
    Food Chem; 2019 Jan; 271():70-79. PubMed ID: 30236734
    [TBL] [Abstract][Full Text] [Related]  

  • 18. alpha-Glucosidase inhibitory action of natural acylated anthocyanins. 1. Survey of natural pigments with potent inhibitory activity.
    Matsui T; Ueda T; Oki T; Sugita K; Terahara N; Matsumoto K
    J Agric Food Chem; 2001 Apr; 49(4):1948-51. PubMed ID: 11308351
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro and in silico inhibition properties of fucoidan against α-amylase and α-D-glucosidase with relevance to type 2 diabetes mellitus.
    S LS; Raghu C; H A A; P A
    Carbohydr Polym; 2019 Apr; 209():350-355. PubMed ID: 30732817
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The use of the alpha-glucosidase inhibitor acarbose for the treatment of type-2 diabetes mellitus in secondary sulfanilamide resistance].
    Gendeleka GF
    Lik Sprava; 1997; (6):105-7. PubMed ID: 9589946
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.